{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:49:30Z","timestamp":1791373770531,"version":"4.3.1"},"reference-count":96,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mirt"],"DOI":"10.4274\/mirt.galenos.2026.62144","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:59:42Z","timestamp":1777377582000},"source":"Crossref","is-referenced-by-count":0,"title":["PET\/CT Identifies Pubic Melorheostosis with High 68Ga-PSMA Uptake in a Patient with Prostate Cancer"],"prefix":"10.4274","author":[{"given":"Deya Aldeen","family":"Sweedat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Saad","family":"Abdlkadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Al-Ibraheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"ref0","unstructured":"1. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970;18:723-37."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","unstructured":"2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.","journal-title":"J Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","unstructured":"3. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184:387-96.","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nature reviews. Immunology 2012;12:417-30.","DOI":"10.1038\/nri3227"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/lt.23458","article-title":"Role of regulatory T cells in the promotion of transplant tolerance","volume":"18","author":"Shalev","year":"2012","unstructured":"5. Shalev I, Selzner N, Shyu W, Grant D, Levy G. Role of regulatory T cells in the promotion of transplant tolerance. Liver Transpl 2012;18:761-70.","journal-title":"Liver Transpl"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","unstructured":"6. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73.","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","unstructured":"7. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-1.","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","unstructured":"8. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27:18-20.","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ni1437","article-title":"Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3","volume":"8","author":"LM","year":"2007","unstructured":"9. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007;8:277-84.","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","unstructured":"10. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005;6:1142-51.","journal-title":"Nat Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","unstructured":"11. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-87.","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1146\/annurev-immunol-020711-075043","article-title":"Induced CD4+Foxp3+ regulatory T cells in immune tolerance","volume":"30","author":"AM","year":"2012","unstructured":"12. Bilate AM, Lafaille JJ. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev Immunol 2012;30:733-58.","journal-title":"Annu Rev Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4049\/jimmunol.180.1.249","article-title":"Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis","volume":"180","author":"Shalev","year":"2008","unstructured":"13. Shalev I, Liu H, Koscik C, et al. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol 2008;180:249-60.","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","unstructured":"14. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007;8:1353-62.","journal-title":"Nat Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","article-title":"Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism","volume":"174","author":"Gondek","year":"2005","unstructured":"15. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005;174:1783-6.","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.4049\/jimmunol.177.10.6780","article-title":"T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine","volume":"177","author":"Kobie","year":"2006","unstructured":"16. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol 2006;177:6780-6.","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20062129","article-title":"Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression","volume":"204","author":"Bopp","year":"2007","unstructured":"17. Bopp T, Becker C, Klein M, et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007;204: 1303-10.","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","unstructured":"18. Qureshi OS, Zheng Y, Nakamura K, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011;332:600-3.","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.4049\/jimmunol.180.9.5916","article-title":"Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II","volume":"180","author":"Liang","year":"2008","unstructured":"19. Liang B, Workman C, Lee J, et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 2008; 180:5916-26.","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","unstructured":"20. Yu X, Harden K, Gonzalez LC, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 2009;10:48-57.","journal-title":"Nat Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","unstructured":"21. Joller N, Lozano E, Burkett PR, et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 2014;40:569-81.","journal-title":"Immunity"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/geno.2000.6444","article-title":"Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant","volume":"71","author":"Yuwaraj","year":"2001","unstructured":"22. Yuwaraj S, Ding J, Liu M, Marsden PA, Levy GA. Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. Genomics 2001;71:330-8.","journal-title":"Genomics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.172.9.5693","article-title":"Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection","volume":"172","author":"Ghanekar","year":"2004","unstructured":"23. Ghanekar A, Mendicino M, Liu H, et al. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol 2004; 172:5693-701.","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0378-1119(95)00240-7","article-title":"Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein","volume":"160","author":"Ruegg","year":"1995","unstructured":"24. Ruegg C, Pytela R. Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein. Gene 1995;160:257-62.","journal-title":"Gene"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4049\/jimmunol.161.1.138","article-title":"Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes","volume":"161","author":"Marazzi","year":"1998","unstructured":"25. Marazzi S, Blum S, Hartmann R, et al. Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol 1998;161: 138-47.","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"51266","DOI":"10.1074\/jbc.M410485200","article-title":"Region-specific expression and secretion of the fibrinogen-related protein, fgl2, by epithelial cells of the hamster epididymis and its role in disposal of defective spermatozoa","volume":"279","author":"Olson","year":"2004","unstructured":"26. Olson GE, Winfrey VP, NagDas SK, Melner MH. Region-specific expression and secretion of the fibrinogen-related protein, fgl2, by epithelial cells of the hamster epididymis and its role in disposal of defective spermatozoa. J Biol Chem 2004;279: 51266-74.","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0021-9258(18)52364-4","article-title":"Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection","volume":"266","author":"Fung","year":"1991","unstructured":"27. Fung LS, Neil G, Leibowitz J, et al. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J Biol Chem 1991;266:1789-95.","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000321882","article-title":"The primary role of fibrinogen-related proteins in invertebrates is defense, not coagulation","volume":"3","author":"PC","year":"2011","unstructured":"28. Hanington PC, Zhang SM. The primary role of fibrinogen-related proteins in invertebrates is defense, not coagulation. J Innate Immun 2011;3:17-27.","journal-title":"J Innate Immun"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"32222","DOI":"10.1074\/jbc.273.48.32222","article-title":"Murine hepatitis virus strain 3 induces the macrophage prothrombinase fgl-2 through p38 mitogen-activated protein kinase activation","volume":"273","author":"McGilvray","year":"1998","unstructured":"29. McGilvray ID, Lu Z, Wei AC, et al. Murine hepatitis virus strain 3 induces the macrophage prothrombinase fgl-2 through p38 mitogen-activated protein kinase activation. J Biol Chem 1998;273:32222-9.","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.biocel.2012.10.014","article-title":"Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2","volume":"45","author":"Liu","year":"2013","unstructured":"30. Liu H, Yang PS, Zhu T, et al. Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2. Int J Biochem Cell Biol 2013;45:408-18.","journal-title":"Int J Biochem Cell Biol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1172\/JCI18114","article-title":"The Fgl2\/ fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis","volume":"112","author":"Marsden","year":"2003","unstructured":"31. Marsden PA, Ning Q, Fung LS, et al. The Fgl2\/ fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 2003;112:58-66.","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/molehr\/7.2.185","article-title":"Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2","volume":"7","author":"Clark","year":"2001","unstructured":"32. Clark DA, Ding JW, Yu G, Levy GA, Gorczynski RM. Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod 2001;7:185-94.","journal-title":"Mol Hum Reprod"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1373\/clinchem.2007.074401","article-title":"Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia","volume":"53","author":"Wang","year":"2007","unstructured":"33. Wang CC, Yim KW, Poon TC, et al. Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin Chem 2007;53:42-52.","journal-title":"Clin Chem"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood 2009;114:2367-74.","DOI":"10.1182\/blood-2009-05-199208"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.ircmb.2015.01.003","article-title":"New insights into the role of ficolins in the lectin pathway of innate immunity","volume":"316","author":"Endo","year":"2015","unstructured":"35. Endo Y, Matsushita M, Fujita T. New insights into the role of ficolins in the lectin pathway of innate immunity. Int Rev Cell Mol Biol 2015;316:49-110.","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4","volume":"167","author":"Smiley","year":"2001","unstructured":"36. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001;167:2887-94.","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nature05563","article-title":"Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells","volume":"445","author":"Zheng","year":"2007","unstructured":"37. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007;445:936-40.","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.4049\/jimmunol.178.7.4230","article-title":"Mouse TCRalphabeta+CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses","volume":"178","author":"Denning","year":"2007","unstructured":"38. Denning TL, Granger SW, Mucida D, et al. Mouse TCRalphabeta+CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses. J Immunol 2007;178:4230-9.","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4049\/jimmunol.1000120","article-title":"Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance","volume":"185","author":"XL","year":"2010","unstructured":"39. Li XL, Menoret S, Bezie S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol 2010;185: 823-33.","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.4049\/jimmunol.170.8.4036","article-title":"Soluble fibrinogen-like protein 2\/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells","volume":"170","author":"Chan","year":"2003","unstructured":"40. Chan CW, Kay LS, Khadaroo RG, et al. Soluble fibrinogen-like protein 2\/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol 2003; 170:4036-44.","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1002\/eji.200838338","article-title":"The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression","volume":"38","author":"Liu","year":"2008","unstructured":"41. Liu H, Shalev I, Manuel J, et al. The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. Eur J Immunol 2008;38: 3114-26.","journal-title":"Eur J Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ni1151","article-title":"The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells","volume":"6","author":"Fukuyama","year":"2005","unstructured":"42. Fukuyama H, Nimmerjahn F, Ravetch JV. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol 2005;6:99-106.","journal-title":"Nat Immunol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.4049\/jimmunol.1302934","article-title":"Inhibitory Fcgamma receptor is required for the maintenance of tolerance through distinct mechanisms","volume":"192","author":"Li","year":"2014","unstructured":"43. Li F, Smith P, Ravetch JV. Inhibitory Fcgamma receptor is required for the maintenance of tolerance through distinct mechanisms. J Immunol 2014;192: 3021-8.","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","article-title":"Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis","volume":"13","author":"Bolland","year":"2000","unstructured":"44. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000;13: 277-85.","journal-title":"Immunity"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.4049\/jimmunol.1101194","article-title":"The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility","volume":"187","author":"Boross","year":"2011","unstructured":"45. Boross P, Arandhara VL, Martin-Ramirez J, et al. The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility. J Immunol 2011;187:1304-13.","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/MOT.0b013e32834017ae","article-title":"CD4+ regulatory T cells in solid organ transplantation","volume":"15","author":"Issa","year":"2010","unstructured":"46. Issa F, Wood KJ. CD4+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant 2010;15:757-64.","journal-title":"Curr Opin Organ Transplant"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI200320274","article-title":"The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery","volume":"112","author":"Sakaguchi","year":"2003","unstructured":"47. Sakaguchi S. The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J Clin Invest 2003;112:1310-12.","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1182\/blood-2004-03-1211","article-title":"Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells","volume":"105","author":"Levings","year":"2005","unstructured":"48. Levings M, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo M. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005;105:1162-9.","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/imm.12354","article-title":"The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts","volume":"144","author":"Urbanellis","year":"2015","unstructured":"49. Urbanellis P, Shyu W, Khattar R, et al. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts. Immunology 2015;144:91-106.","journal-title":"Immunology"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50. Tang Q, Bluestone JA. Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med 2013;3(11).","DOI":"10.1101\/cshperspect.a015552"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","unstructured":"51. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008;14:88-92.","journal-title":"Nat Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cellimm.2011.05.006","article-title":"Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation","volume":"270","author":"Shan","year":"2011","unstructured":"52. Shan J, Guo Y, Luo L, et al. Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation. Cell Immunol 2011;270:5-12.","journal-title":"Cell Immunol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/hep.25579","article-title":"Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients","volume":"57","author":"Levitsky","year":"2013","unstructured":"53. Levitsky J, Mathew JM, Abecassis M, et al. Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. Hepatology 2013;57:239-48.","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54. Bezie S, Picarda E, Tesson L, et al. Fibrinogen-like protein 2\/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells. PLoS One 2015;10:e0119686.","DOI":"10.1371\/journal.pone.0119686"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T cells in human autoimmune diseases","volume":"117","author":"Dejaco","year":"2006","unstructured":"55. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 2006;117: 289-300.","journal-title":"Immunology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1600-065X.2008.00637.x","article-title":"Human regulatory T cells: role in autoimmune disease and therapeutic opportunities","volume":"223","author":"Brusko","year":"2008","unstructured":"56. Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008;223: 371-90.","journal-title":"Immunol Rev"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1016\/j.febslet.2011.07.043","article-title":"Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis","volume":"585","author":"KM","year":"2011","unstructured":"57. Chavele KM, Ehrenstein MR. Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 2011;585:3603-10.","journal-title":"FEBS Lett"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1097\/MIB.0b013e31829ed7df","article-title":"Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease","volume":"19","author":"Gibson","year":"2013","unstructured":"58. Gibson DJ, Ryan EJ, Doherty GA. Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2716-24.","journal-title":"Inflamm Bowel Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-014-8440-0","article-title":"Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review","volume":"47","author":"Tan","year":"2014","unstructured":"59. Tan T, Xiang Y, Chang C, Zhou Z. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. Clin Rev Allergy Immunol 2014;47:234-43.","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60. You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc Natl Acad Sci U S A 2004; 101(Suppl 2):14580-5.","DOI":"10.1073\/pnas.0404870101"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.4049\/jimmunol.0803827","article-title":"Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function","volume":"182","author":"Tran","year":"2009","unstructured":"61. Tran DQ, Glass DD, Uzel G, et al. Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol 2009;182:2929-38.","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/ncpneuro0832","article-title":"The role of regulatory T cells in multiple sclerosis","volume":"4","author":"AL","year":"2008","unstructured":"62. Zozulya AL, Wiendl H. The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol 2008;4: 384-98.","journal-title":"Nat Clin Pract Neurol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jneuroim.2009.06.011","article-title":"Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis","volume":"216","author":"Haas","year":"2009","unstructured":"63. Haas J, Korporal M, Balint B, Fritzsching B, Schwarz A, Wildemann B. Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis. J Neuroimmunol 2009;216: 113-17.","journal-title":"J Neuroimmunol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1001\/archneur.65.11.1434","article-title":"Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells","volume":"65","author":"Korporal","year":"2008","unstructured":"64. Korporal M, Haas J, Balint B, et al. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells. Arch Neurol 2008;65:1434-9.","journal-title":"Arch Neurol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fonc.2014.00209","article-title":"Utilizing regulatory T cells against rheumatoid arthritis","volume":"4","author":"Haque","year":"2014","unstructured":"65. Haque M, Fino K, Lei F, Xiong X, Song J. Utilizing regulatory T cells against rheumatoid arthritis. Front Oncol 2014;4:209.","journal-title":"Front Oncol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10620-013-2962-9","article-title":"Intestinal and peripheral fibrinogen-like protein 2 expression in inflammatory bowel disease","volume":"59","author":"Dong","year":"2014","unstructured":"66. Dong X, Ye X, Chen X, et al. Intestinal and peripheral fibrinogen-like protein 2 expression in inflammatory bowel disease. Dig Dis Sci 2014;59:769-77.","journal-title":"Dig Dis Sci"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1559-0275-11-1","article-title":"Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients","volume":"11","author":"Balakrishnan","year":"2014","unstructured":"67. Balakrishnan L, Bhattacharjee M, Ahmad S, et al. Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients. Clin Proteomics 2014;11:1.","journal-title":"Clin Proteomics"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/intimm\/5.11.1461","article-title":"B-17 scid mice","volume":"5","author":"Powrie","year":"1993","unstructured":"68. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-71.","journal-title":"Int Immunol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/imr.12085","article-title":"Role of regulatory T cells during virus infection","volume":"255","author":"Veiga-Parga","year":"2013","unstructured":"69. Veiga-Parga T, Sehrawat S, Rouse BT. Role of regulatory T cells during virus infection. Immunol Rev 2013;255:182-96.","journal-title":"Immunol Rev"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2567.2007.02691.x","article-title":"Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection","volume":"123","author":"Peng","year":"2008","unstructured":"70. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008;123: 57-65.","journal-title":"Immunology"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"806061","DOI":"10.1155\/2011\/806061","article-title":"Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses","volume":"2011","author":"Cusick","year":"2011","unstructured":"71. Cusick MF, Schiller JJ, Gill JC, Eckels DD. Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses. Clin Dev Immunol 2011;2011:806061.","journal-title":"Clin Dev Immunol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","article-title":"The split personality of regulatory T cells in HIV infection","volume":"121","author":"MF","year":"2013","unstructured":"72. Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood 2013;121:29-37.","journal-title":"Blood"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"73. Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, Wang FS. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 2010;5:e13869.","DOI":"10.1371\/journal.pone.0013869"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/imm.12330","article-title":"Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C","volume":"143","author":"Hao","year":"2014","unstructured":"74. Hao C, Zhou Y, He Y, et al. Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C. Immunology 2014;143:531-8.","journal-title":"Immunology"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/hep.22684","article-title":"The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis","volume":"49","author":"Shalev","year":"2009","unstructured":"75. Shalev I, Wong KM, Foerster K, et al. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 2009;49:387-97.","journal-title":"Hepatology"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"76. Khattar R, Luft O, Yavorska N, et al. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE. PLoS One 2013;8:e72309.","DOI":"10.1371\/journal.pone.0072309"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/hum.2006.17.589","article-title":"Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB\/cJ mice","volume":"17","author":"Zhu","year":"2006","unstructured":"77. Zhu C, Sun Y, Luo X, Yan W, Xi D, Ning Q. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB\/cJ mice. Hum Gene Ther 2006;17:589-600.","journal-title":"Hum Gene Ther"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2010.04.020","article-title":"The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection","volume":"53","author":"Foerster","year":"2010","unstructured":"78. Foerster K, Helmy A, Zhu Y, et al. The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. J Hepatol 2010;53:608-15.","journal-title":"J Hepatol"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"79. Shalev I, Selzner N, Helmy A, et al. The role of FGL2 in the pathogenesis and treatment of hepatitis C virus infection. Rambam Maimonides Med J 2010;1: e0004.","DOI":"10.5041\/RMMJ.10004"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11596-012-0093-8","article-title":"Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B","volume":"32","author":"Xu","year":"2012","unstructured":"80. Xu L, Yang D, Liu Y, Wu D, Wang X, Ning Q. Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B. J Huazhong Univ Sci Technolog Med Sci 2012;32:540-5.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"81. Adeegbe DO, Nishikawa H. Natural and induced T regulatory cells in cancer. Front Immunol 2013;4: 190.","DOI":"10.3389\/fimmu.2013.00190"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.2353\/ajpath.2010.090950","article-title":"Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications","volume":"176","author":"Tyburczy","year":"2010","unstructured":"82. Tyburczy ME, Kotulska K, Pokarowski P, et al. Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications. Am J Pathol 2010;176:1878-90.","journal-title":"Am J Pathol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/j.1478-3231.2012.02865.x","article-title":"Downregulation of FGL2\/ prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis","volume":"32","author":"Liu","year":"2012","unstructured":"83. Liu Y, Xu L, Zeng Q, et al. Downregulation of FGL2\/ prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int 2012;32:1585-95.","journal-title":"Liver Int"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"84. Birkhauser FD, Koya RC, Neufeld C, et al. Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM.CAIX in immunocompetent mouse models. J Immunother 2013;36:102-11.","DOI":"10.1097\/CJI.0b013e31827bec97"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"85. Yan J, Kong LY, Hu J, et al. FGL2 as a multimodality regulator of tumor-mediated immune suppression and therapeutic target in gliomas. J Natl Cancer Inst 2015;107.","DOI":"10.1093\/jnci\/djv137"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneph.2015.2","article-title":"Transplantation: biomarkers in transplantation-the devil is in the detail","volume":"11","author":"Abecassis","year":"2015","unstructured":"86. Abecassis M, Kaplan B. Transplantation: biomarkers in transplantation-the devil is in the detail. Nat Rev Nephrol 2015;11:204-5.","journal-title":"Nat Rev Nephrol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/lt.22480","article-title":"Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance","volume":"18","author":"Xie","year":"2012","unstructured":"87. Xie L, Ichimaru N, Morita M, et al. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl 2012;18:444-54.","journal-title":"Liver Transpl"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2047-1440-2-17","article-title":"Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study","volume":"2","author":"Streitz","year":"2013","unstructured":"88. Streitz M, Miloud T, Kapinsky M, et al. Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplant Res 2013;2:17.","journal-title":"Transplant Res"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1586\/eci.10.96","article-title":"Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity","volume":"7","author":"Wright","year":"2011","unstructured":"89. Wright GP, Ehrenstein MR, Stauss HJ. Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity. Expert Rev Clin Immunol 2011;7: 213-25.","journal-title":"Expert Rev Clin Immunol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2567.2012.03572.x","article-title":"Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers","volume":"136","author":"Himmel","year":"2012","unstructured":"90. Himmel ME, Yao Y, Orban PC, Steiner TS, Levings MK. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology 2012;136:115-22.","journal-title":"Immunology"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/ajt.12647","article-title":"Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning","volume":"14","author":"Juvet","year":"2014","unstructured":"91. Juvet SC, Whatcott AG, Bushell AR, Wood KJ. Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning. Am J Transplant 2014;14:750-63.","journal-title":"Am J Transplant"},{"key":"ref91","unstructured":"92. Vinay DS, Ryan EP, Pawelec G, et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol 2015 Mar 25. [Epub ahead of print]"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","unstructured":"93. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.","journal-title":"Cell"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Nishikawa","year":"2014","unstructured":"94. Nishikawa H, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Curr Opin Immunol 2014; 27:1-7.","journal-title":"Curr Opin Immunol"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"95. Pizzurro GA, Barrio MM. Dendritic cell-based vaccine efficacy: aiming for hot spots. Front Immunol 2015; 6:91.","DOI":"10.3389\/fimmu.2015.00091"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"96. Wang J, Vuitton DA, Muller N, et al. Deletion of fibrinogen-like protein 2 (FGL-2), a novel CD4+ CD25+ Treg effector molecule, leads to improved control of Echinococcus multilocularis infection in mice. PLoS Negl Trop Dis 2015;9:e0003755.","DOI":"10.1371\/journal.pntd.0003755"}],"container-title":["Molecular Imaging and Radionuclide Therapy"],"original-title":[],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:50:20Z","timestamp":1791370220000},"score":1,"resource":{"primary":{"URL":"https:\/\/mirt.tsnmjournals.org\/articles\/petct-identifies-pubic-melorheostosis-with-high-lesssupgreater68lesssupgreaterga-psma-uptake-in-a-patient-with-prostate-cancer\/doi\/mirt.galenos.2026.62144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":96,"URL":"https:\/\/doi.org\/10.4274\/mirt.galenos.2026.62144","relation":{},"ISSN":["2146-1414","2147-1959"],"issn-type":[{"value":"2146-1414","type":"print"},{"value":"2147-1959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}